Veracyte | VCYT - Loan Capital


Veracyte reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.





Loan Capital Change Date
Agenus USD 153.98M 15.68M Mar/2026
Agilent USD 3.64B 594M Jun/2026
Arrowhead Research USD 824.07M 401.34M Jun/2026
Bruker USD 1.81B 151.8M Jun/2026
Heron Therapeutics USD 140.64M 975K Dec/2025
Illumina USD 1.49B 1000K Jun/2026
Intrexon USD 0 198.67M Jun/2024
Karyopharm Therapeutics USD 264.49M 13.73M Mar/2026
Laboratory Of America USD 5.92B 23.3M Jun/2026
Ligand Pharmaceuticals USD 446.9M 704K Mar/2026
Myriad Genetics USD 120.7M 400K Jun/2026
Rigel Pharmaceuticals USD 0 0 Sep/2024
Roche Holding CHF 25.22B 2.21B Jun/2026
Sangamo BioSciences USD 0 0 Jun/2022
Siemens EUR 41.32B 199M Jun/2026
Sonic Healthcare AUD 4.19B 333.39M Dec/2024
Thermo Fisher Scientific USD 39.18B 890M Jun/2026
Veracyte USD 0 0 Mar/2025
Waters USD 5.09B 129M Jun/2026